3.20.2 html 99 277 1 false 16 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://actiniumpharmaceuticals.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://actiniumpharmaceuticals.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://actiniumpharmaceuticals.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://actiniumpharmaceuticals.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statement of Changes in Stockholders??? Equity (Unaudited) Sheet http://actiniumpharmaceuticals.com/role/ShareholdersEquityType2or3 Consolidated Statement of Changes in Stockholders??? Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://actiniumpharmaceuticals.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Description of Business and Summary of Significant Accounting Policies Sheet http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPolicies Description of Business and Summary of Significant Accounting Policies Notes 7 false false R8.htm 007 - Disclosure - Commitments and Contingencies Sheet http://actiniumpharmaceuticals.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 8 false false R9.htm 008 - Disclosure - Leases Sheet http://actiniumpharmaceuticals.com/role/Leases Leases Notes 9 false false R10.htm 009 - Disclosure - Equity Sheet http://actiniumpharmaceuticals.com/role/Equity Equity Notes 10 false false R11.htm 010 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://actiniumpharmaceuticals.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPolicies 11 false false R12.htm 011 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Tables) Sheet http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables Description of Business and Summary of Significant Accounting Policies (Tables) Tables http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPolicies 12 false false R13.htm 012 - Disclosure - Leases (Tables) Sheet http://actiniumpharmaceuticals.com/role/LeasesTables Leases (Tables) Tables http://actiniumpharmaceuticals.com/role/Leases 13 false false R14.htm 013 - Disclosure - Equity (Tables) Sheet http://actiniumpharmaceuticals.com/role/EquityTables Equity (Tables) Tables http://actiniumpharmaceuticals.com/role/Equity 14 false false R15.htm 014 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details) Sheet http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails Description of Business and Summary of Significant Accounting Policies (Details) Details http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables 15 false false R16.htm 015 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details) - Schedule of cash and cash equivalent and restricted cash Sheet http://actiniumpharmaceuticals.com/role/ScheduleofcashandcashequivalentandrestrictedcashTable Description of Business and Summary of Significant Accounting Policies (Details) - Schedule of cash and cash equivalent and restricted cash Details http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables 16 false false R17.htm 016 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details) - Schedule of antidilutive securities excluded from computation of diluted net loss per share Sheet http://actiniumpharmaceuticals.com/role/ScheduleofantidilutivesecuritiesexcludedfromcomputationofdilutednetlosspershareTable Description of Business and Summary of Significant Accounting Policies (Details) - Schedule of antidilutive securities excluded from computation of diluted net loss per share Details http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables 17 false false R18.htm 017 - Disclosure - Commitments and Contingencies (Details) Sheet http://actiniumpharmaceuticals.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://actiniumpharmaceuticals.com/role/CommitmentsandContingencies 18 false false R19.htm 018 - Disclosure - Leases (Details) - Schedule components of lease expense Sheet http://actiniumpharmaceuticals.com/role/SchedulecomponentsofleaseexpenseTable Leases (Details) - Schedule components of lease expense Details http://actiniumpharmaceuticals.com/role/LeasesTables 19 false false R20.htm 019 - Disclosure - Leases (Details) - Schedule of supplemental cash flow information related to leases Sheet http://actiniumpharmaceuticals.com/role/ScheduleofsupplementalcashflowinformationrelatedtoleasesTable Leases (Details) - Schedule of supplemental cash flow information related to leases Details http://actiniumpharmaceuticals.com/role/LeasesTables 20 false false R21.htm 020 - Disclosure - Leases (Details) - Weighted average remaining lease terms are as follows at September 30, 2020: Sheet http://actiniumpharmaceuticals.com/role/WeightedaverageremainingleasetermsareasfollowsatSeptember302020Table Leases (Details) - Weighted average remaining lease terms are as follows at September 30, 2020: Details http://actiniumpharmaceuticals.com/role/LeasesTables 21 false false R22.htm 021 - Disclosure - Leases (Details) - Schedule of weighted average discount rates Sheet http://actiniumpharmaceuticals.com/role/ScheduleofweightedaveragediscountratesTable Leases (Details) - Schedule of weighted average discount rates Details http://actiniumpharmaceuticals.com/role/LeasesTables 22 false false R23.htm 022 - Disclosure - Leases (Details) - Schedule of maturities of lease liabilities Sheet http://actiniumpharmaceuticals.com/role/ScheduleofmaturitiesofleaseliabilitiesTable Leases (Details) - Schedule of maturities of lease liabilities Details http://actiniumpharmaceuticals.com/role/LeasesTables 23 false false R24.htm 023 - Disclosure - Equity (Details) Sheet http://actiniumpharmaceuticals.com/role/EquityDetails Equity (Details) Details http://actiniumpharmaceuticals.com/role/EquityTables 24 false false R25.htm 024 - Disclosure - Equity (Details) - Schedule of stock option activities Sheet http://actiniumpharmaceuticals.com/role/ScheduleofstockoptionactivitiesTable Equity (Details) - Schedule of stock option activities Details http://actiniumpharmaceuticals.com/role/EquityTables 25 false false R26.htm 025 - Disclosure - Equity (Details) - Schedule of warrant activities Sheet http://actiniumpharmaceuticals.com/role/ScheduleofwarrantactivitiesTable Equity (Details) - Schedule of warrant activities Details http://actiniumpharmaceuticals.com/role/EquityTables 26 false false R27.htm 026 - Disclosure - Equity (Details) - Schedule of warrant activities Sheet http://actiniumpharmaceuticals.com/role/ScheduleofwarrantactivitiesTable0 Equity (Details) - Schedule of warrant activities Details http://actiniumpharmaceuticals.com/role/EquityTables 27 false false All Reports Book All Reports atnm-20200930.xml atnm-20200930.xsd atnm-20200930_cal.xml atnm-20200930_def.xml atnm-20200930_lab.xml atnm-20200930_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true